Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin
Isabelle Delattre(Cliniques Universitaires Saint-Luc), Pierre Wallemacq(Cliniques Universitaires Saint-Luc), Roger K. Verbeeck(UCLouvain), Flora T. Musuamba(Inserm), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Fabio Silvio Taccone(Université Libre de Bruxelles), Frédérique Jacobs(Université Libre de Bruxelles), Philippe Jacqmin
Cited by 34
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest
|New England Journal of Medicine|2021|979
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890